Background Pelvic inflammatory disease (PID) affects 4% to 12% of women of reproductive
age. The main intervention for acute PID is broad‐spectrum antibiotics administered …

Pelvic inflammatory disease (PID) is common infection among reproductive-aged women.
The presentation ranges from acute severe illness to a more indolent and mild clinical …

Pelvic inflammatory disease (PID) is an infection-caused inflammatory continuum from the
cervix to the peritoneal cavity. Most importantly, it is associated with fallopian tube …

Pelvic inflammatory disease (PID) is one of the most common serious infections of
nonpregnant women of reproductive age. Management of PID is directed at containment of …

Pelvic inflammatory disease, the infection and inflammation of the female upper genital tract,
is a common cause of infertility, chronic pain and ectopic pregnancy. Diagnosis and …

BACKGROUND:: Tinidazole, a structural analogue of metrondazole, is an antiprotozoal
agent that has been widely used in Europe and developing countries for> 2 decades with …

Pelvic inflammatory disease (PID) is a substantial cause of reproductive morbidity in young
women. A systematic review of the literature related to PID management was performed in …

OBJECTIVE: To evaluate the equivalence of ceftriaxone plus doxycycline or azithromycin for
cases of mild pelvic inflammatory disease (PID). METHODS: Patients with PID received an …

Antimicrobial resistance is a significant global issue that has increased mortality rates over
the past 100 years. One of the strategies followed to overcome this problem is to use …

Objective To assess the effectiveness and safety of antibiotic regimens used to treat pelvic
inflammatory disease (PID). Design This is a systematic review and meta-analysis of …